Preclinical and clinical studies have shown that PDE5 inhibition has a beneficial effect not only on improving β cell function [168] but also on increasing insulin sensitivity of other peripheral tissues (skeletal muscle cells, adipocytes, and endothelial cells), thus improving insulin resistance [169,170,171]. This evidence concerns the gene INS and Insulin resistance.